TOVX · Categories · Form 4

TOVX - SEC Form 4 insider transactions

Theriva Biologics Inc. (TOVX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for TOVX

• 155d
  SEC Form 4 filed by CEO and CFO Shallcross Steven A

  4 - Theriva Biologics, Inc. (0000894158) (Issuer)
• 155d
  SEC Form 4 filed by Director Monahan John J

  4 - Theriva Biologics, Inc. (0000894158) (Issuer)
• 155d
  SEC Form 4 filed by Director Kraws Jeffrey J

  4 - Theriva Biologics, Inc. (0000894158) (Issuer)
• 155d
  SEC Form 4 filed by Director Wolf Jeffrey Alan

  4 - Theriva Biologics, Inc. (0000894158) (Issuer)
• 406d
  SEC Form 4 filed by Director Wolf Jeffrey Alan

  4 - Theriva Biologics, Inc. (0000894158) (Issuer)
• 406d
  SEC Form 4 filed by CEO and CFO Shallcross Steven A

  4 - Theriva Biologics, Inc. (0000894158) (Issuer)
• 406d
  SEC Form 4 filed by Director Kraws Jeffrey J

  4 - Theriva Biologics, Inc. (0000894158) (Issuer)
• 406d
  SEC Form 4 filed by Director Monahan John J

  4 - Theriva Biologics, Inc. (0000894158) (Issuer)

Other TOVX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends